Clinical Trial Update: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating a triptolide-containing formulation for autosomal dominant polycystic kidney disease (ADPKD); current trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• Triptolide-containing formulation (Triptolide)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 3 | Status: UNKNOWN